Huxley SANSA Home Sleep Apnea Test (1000-00) vs Reveal LINQ Insertable Cardiac Monitor
AI Verdict
Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…
Choose Huxley SANSA if you need a convenient, app-free, and comprehensive home diagnostic solution for suspected sleep apnea and co-occurring cardiac arrhythmias. Its multi-day monitoring capability and cellular-enabled data upload make it ideal for patients requiring a streamlined, non-invasive assessment without the need for patient interaction with a mobile application.
View Huxley SANSA Home Sleep Apnea Test (1000-00) →Choose Reveal LINQ if…
Choose the Medtronic Reveal LINQ ICM if your patient requires long-term, continuous monitoring for infrequent or unexplained cardiac events, such as syncope or suspected atrial fibrillation, over an extended period. Its implantable nature and 4.5-year battery longevity ensure consistent data capture and diagnostic yield, especially when transient arrhythmias are difficult to detect with shorter-term monitoring.
View Reveal LINQ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Huxley SANSA Home Sleep Apnea Test (1000-00) | Reveal LINQ |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Cloud-native platform, accessible from any browser. | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Huxley SANSA Home Sleep Apnea Test (1000-00)Tool A offers superior patient usability with its non-invasive, wearable chest patch design and an app-free, cellular-enabled workflow. In contrast, Tool B is an implantable device that requires an invasive procedure and relies on patient interaction with a smartphone app or home communicator for data transmission.
Clinical Value
Reveal LINQWhile both tools offer significant clinical value in their respective domains, Tool B provides continuous, long-term (4.5 years) cardiac monitoring with AccuRhythmu2122 AI algorithms specifically designed to reduce false alerts for atrial fibrillation and pauses, enhancing diagnostic yield for chronic conditions. Tool A provides multi-day home sleep apnea and cardiac arrhythmia diagnosis, validated against polysomnography, and recently cleared for central sleep apnea detection, but Tool B's longevity and targeted AI for accuracy in chronic cardiac conditions give it an edge for sustained clinical impact.
Pricing & Value
TieBoth Tool A and Tool B maintain opaque pricing models, requiring direct contact with their respective vendors for specific cost information. Without publicly available pricing details, it is not possible to conduct a comparative assessment of their value propositions based on cost.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Both also leverage cloud-based platforms for data management, fulfilling essential requirements for integration into healthcare organizational workflows.
Innovation
Reveal LINQTool B's AccuRhythmu2122 AI algorithms, integrated into an implantable cardiac monitor for reducing false alerts over a 4.5-year battery life, represent a highly targeted and impactful innovation in long-term cardiac monitoring accuracy. While Tool A's app-free, cellular-enabled multi-channel wearable is innovative for simplifying home diagnostics, Tool B's AI directly addresses a critical clinical challenge of false positives in chronic monitoring.
Support & Docs
Reveal LINQMedtronic (Tool B) offers a significantly more comprehensive and robust support infrastructure, including dedicated technical services, patient services, extensive online patient education materials, setup guides, troubleshooting, product manuals, and remote technical assistance via CareLinku2122 Assist. Huxley Medical (Tool A) provides 24/7 live support, online support, and customer service contact, but Medtronic's established and multi-faceted support system appears more extensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Huxley SANSA Home Sleep Apnea Test (1000-00) | Reveal LINQ |
|---|---|---|
| Name | Huxley SANSA Home Sleep Apnea Test (1000-00) | Reveal LINQ Insertable Cardiac Monitor |
| Company | Huxley Medical | Medtronic |
| Device Type | Wearable chest patch | Implantable device |
| Primary Diagnostic Focus | Home sleep apnea and cardiac arrhythmia diagnosis | Long-term accurate heart monitoring (e.g., atrial fibrillation, syncope) |
| AI Capabilities | AI-powered auto-scoring algorithms | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause) |
| Data Transmission Method | Built-in cellular data upload (app-free workflow) | Data transmitted via patient smartphone app (MyCareLink Heartu2122) or home communicator (MyCareLink Relayu2122) |
| Monitoring Duration/Battery Life | Multi-day monitoring capability | 4.5-year battery longevity (nominal settings) |
| Physiological Data Channels | 9 physiological data channels (ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging) | Continuous, long-term subcutaneous ECG monitoring |
Videos
Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and Reveal LINQ.